HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Cellyan Biotechnology Co., Ltd
Financials through fiscal 2025, year ended Mar 31, 2025Last filing: 20-F on Aug 7, 2026
$0.11+0.00 (+1.81%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
18 of Cellyan Biotechnology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 6-K | Oct 21, 2026 | Oct 21, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 23, 2026 | Sep 24, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 9, 2026 | Sep 10, 2026 | SEC EDGAR |
| Annual report | 20-F | Mar 31, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 6-K | Jul 16, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 6-K | Mar 26, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 6-K | Sep 30, 2025 | Mar 18, 2026 | SEC EDGAR |
| Current report | 6-K | Jan 16, 2026 | Jan 16, 2026 | SEC EDGAR |
| Current report | 6-K | Dec 30, 2025 | Dec 31, 2025 | SEC EDGAR |
| Current report | 6-K | Dec 17, 2025 | Dec 17, 2025 | SEC EDGAR |
| Current report | 6-K | Nov 24, 2025 | Nov 24, 2025 | SEC EDGAR |
| Current report | 6-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 6-K | Oct 6, 2025 | Oct 7, 2025 | SEC EDGAR |
| Current report | 6-K | Sep 11, 2025 | Sep 11, 2025 | SEC EDGAR |
| Annual report | 20-F | Mar 31, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 6-K | Mar 28, 2025 | Mar 28, 2025 | SEC EDGAR |
| Current report | 6-K | Jan 17, 2025 | Jan 17, 2025 | SEC EDGAR |